Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522961 · ClinicalTrials.gov registry record · NA
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
A NA study of Urinary Incontinence and Pelvic Organ Prolapse, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 142
- Enrollment target
- 1
- Study location
NCT03522961: Active NA study of Urinary Incontinence and Pelvic Organ Prolapse, sponsored by Brigham and Women's Hospital.
NCT03522961 is a NA study of Urinary Incontinence and Pelvic Organ Prolapse that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 142 participants, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03522961, a NA study of Urinary Incontinence and Pelvic Organ Prolapse, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
- 1
- Study location
Study Summary
We aim to compare the effectiveness of cranberry capsules versus nitrofurantoin prophylaxis in preventing urinary tract infections (UTIs) after urogynecologic surgery by conducting a double-blinded randomized clinical trial involving women with pelvic organ prolapse and/or urinary incontinence scheduled to have surgery with the Urogynecologists who comprise the Brigham and Women's Urogynecology Group.
Primary Outcome
Clinically suspected treatment will include both empiric treatment based on the development of urinary symptoms alone (dysuria, urinary urgency, and/or urinary frequency) or prescribed based on symptoms suggestive of a UTI and the presence of nitrites and/or leukocyte esterase on urine dipstick analysis. Participants will fill out a daily catheterization and medication diary which asks about the presence or absence of UTI symptoms. They will be encouraged to call the office and/or come in for ev
Conditions Studied
Interventions
- DRUG Nitrofurantoin Prophylaxis/Placebo
- DRUG Cranberry capsules
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT03522961 still lists
NCT03522961 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (45% lower).
The record links to 3 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Nitrofurantoin Prophylaxis/Placebo is the first listed.
NCT03522961 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03522961 about?
NCT03522961 is a clinical study titled "Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery". We aim to compare the effectiveness of cranberry capsules versus nitrofurantoin prophylaxis in preventing urinary tract infections (UTIs) after urogynecologic surgery by conducting a double-blinded randomized clinical trial involving women with pelvic organ prolapse and/or urinary incontinence sched...
What is the current status of trial NCT03522961?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2018-08-15. Estimated completion is 2026-12-31.
What conditions does trial NCT03522961 study?
This clinical trial studies the following conditions: Urinary Incontinence, Pelvic Organ Prolapse, Urinary Tract Infections.
What interventions are being tested in trial NCT03522961?
The interventions under investigation include: Nitrofurantoin Prophylaxis/Placebo (DRUG), Cranberry capsules (DRUG).
Who is sponsoring clinical trial NCT03522961?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03522961 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03522961's enrollment target sits among peer trials
142 19th of 48 higher than 30 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI